Recent studies show that GM-CSF blockade has a therapeutic effect against cardiac inflammation during Kawasaki disease or aortic aneurysm formation46, as well as against lung diseases such as COPD47, interstitial lung disease48, allergy49and asthma50. This evidence concerns the gene CSF2 and lung disorder.